0000904454-13-001105.txt : 20131011
0000904454-13-001105.hdr.sgml : 20131011
20131011172015
ACCESSION NUMBER: 0000904454-13-001105
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130924
FILED AS OF DATE: 20131011
DATE AS OF CHANGE: 20131011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
CITY: SAN DIEGO
STATE: CA
ZIP: 92122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TIDMARSH GEORGE F
CENTRAL INDEX KEY: 0001287235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24274
FILM NUMBER: 131148627
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-09-24
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001287235
TIDMARSH GEORGE F
4370 LA JOLLA VILLAGE DRIVE
SUITE 400
SAN DIEGO
CA
92122
1
1
0
0
Pres, CEO, Sec'y
Common Stock
2013-09-24
4
A
0
66352429
A
68332871
D
Stock Option (Right to Buy)
.06
2012-04-10
4
D
0
506300087
D
2022-04-10
Common Stock
506300087
0
D
On September 24, 2013, the Issuer cancelled, pursuant to the Restricted Stock Purchase Agreement entered into and between the Issuer and the Reporting Person, an option granted to the Reporting Person on April 10, 2012. In exchange for the forfeiture of the option and the RSUs, the Reporting Person received 66,352,429 shares of restricted Common Stock.
The cancelled option provided for vesting with respect to one-quarter of the underlying shares on January 19, 2013 and, with respect to the remaining shares, monthly thereafter over the next three years.
/s/ George F. Tidmarsh
2013-10-09